FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 151 through 200 of 277

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
KOD Nasdaq Kodiak Sciences Inc. 2830
KTTA Nasdaq Pasithea Therapeutics Corp. 2830
KVUE New York Kenvue Inc. 2830
KYTX Nasdaq Kyverna Therapeutics, Inc. 2830
LENZ Nasdaq LENZ Therapeutics, Inc. 2830
LFCR Nasdaq Lifecore Biomedical, Inc. 2830
LIMN Nasdaq Liminatus Pharma, Inc. 2830
LITS Nasdaq Lite Strategy, Inc. 2830
LIXT Nasdaq Lixte Biotechnology Holdings, Inc. 2830
LNAI Nasdaq Lunai Bioworks Inc. 2830
LPCN Nasdaq Lipocine Inc. 2830
LQDA Nasdaq Liquidia Corporation 2830
LRMR Nasdaq Larimar Therapeutics, Inc. 2830
LSTA Nasdaq Lisata Therapeutics, Inc. 2830
LTRN Nasdaq Lantern Pharma Inc. 2830
LXEO Nasdaq Lexeo Therapeutics, Inc. 2830
LXRX Nasdaq Lexicon Pharmaceuticals, Inc. 2830
MAZE Nasdaq Maze Therapeutics, Inc. 2830
MBX Nasdaq MBX Biosciences, Inc. 2830
MDCX Nasdaq Medicus Pharma Ltd. 2830
MDWD Nasdaq MediWound Ltd. 2830
MIST Nasdaq Milestone Pharmaceuticals Inc. 2830
MNMD Nasdaq Mind Medicine (MindMed) Inc. 2830
MNOV Nasdaq MediciNova, Inc. 2830
MOLN Nasdaq Molecular Partners AG 2830
MRK New York Merck & Co., Inc. 2830
MRNA Nasdaq Moderna, Inc. 2830
MTNB NYSE American Matinas BioPharma Holdings, Inc. 2830
NAGE Nasdaq Niagen Bioscience, Inc. 2830
NBTX Nasdaq Nanobiotix S.A. 2830
NBY NYSE American NovaBay Pharmaceuticals, Inc. 2830
NCEL Nasdaq NewcelX Ltd. 2830
NCNA Nasdaq NuCana plc 2830
NKTR Nasdaq Nektar Therapeutics 2830
NMRA Nasdaq Neumora Therapeutics, Inc. 2830
NNVC NYSE American NanoViricides, Inc. 2830
NRIX Nasdaq Nurix Therapeutics, Inc. 2830
NRXP Nasdaq NRx Pharmaceuticals, Inc. 2830
NSRX NYSE American Nasus Pharma Ltd. 2830
NUVL Nasdaq Nuvalent, Inc. 2830
NVO New York Novo Nordisk A/S 2830
NXTC Nasdaq NextCure, Inc. 2830
OCS Nasdaq Oculis Holding AG 2830
OGEN NYSE American Oragenics, Inc. 2830
OKUR Nasdaq OnKure Therapeutics, Inc. 2830
OMER Nasdaq Omeros Corporation 2830
ONCO Nasdaq Onconetix, Inc. 2830
ONCY Nasdaq Oncolytics Biotech Inc. 2830
OPHLY Over the counter Ono Pharmaceutical Co., Ltd. 2830
ORIC Nasdaq ORIC Pharmaceuticals, Inc. 2830
Results 150 through 200 of 277